Home » Newsletters » BioWorld Science

BioWorld Science

April 12, 1999

View Archived Issues

Liposomal amphotericin B effective for empirical antifungal therapy

PEG used to repair cut nerve fibers in animal models

LeukoSite and Ilex hold pre-BLA meeting with FDA

Special report on peridural fibrosis includes positive results for ADCON-L

Genset reaches milestone in prostate cancer collaboration with Synthelabo

Addition of Canadian sites to phase III WF-10 AIDS trial approved

Fujisawa and NeXstar team up to identify new immunological agents

Chemokine receptor modulators claimed by Merck for HIV/AIDS prevention or treatment

Idec's humanized murine antibody enters phase II testing for SLE

Korea research institute describes new compounds with reversible antisecretory activity

SangStat's ciclosporin capsules filed for approval in U.K.

ADIR prepares structurally novel compounds as venotropic agents

Preliminary clinical results for ABT-627 presented at this week's AACR meeting

Epimmune publishes studies on hepatitis, malaria vaccine development

AACR presentation for BN-80915, an improved camptothecin analogue

Sertoli and JDF enter cellular therapy collaboration for type I diabetes

Synthetic peptide from Demegen selectively targets cancerous prostate cells in vitro

Grape seed extract shown to downregulate HIV-1 coreceptors

Preclinical results support clinical evaluation of BCH-4556 for prostate cancer

SBIR grant to Phytera for antibacterial drug discovery technology

Aplidine: mechanism of antitumor activity is explored

Preclinical and clinical results with Virulizin in pancreatic cancer presented at AACR meeting

Organon Teknika licenses potent analgesic from Delta

Delsys and R.W. Johnson to collaborate on solid oral drug delivery technology

Design, preclinical toxicity of VNP-20009, a genetically modified Salmonella strain for solid tumors

Genome Pharmaceuticals and Evotec BioSystems enter drug discovery alliance

Calydon presents preclinical data on novel ARCA compound for prostate tumors

Zila and U. of Chicago jointly develop diagnostic tests for cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...